<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00993785</url>
  </required_header>
  <id_info>
    <org_study_id>CP-04</org_study_id>
    <nct_id>NCT00993785</nct_id>
  </id_info>
  <brief_title>CoStar Catheter System Evaluation</brief_title>
  <acronym>CONCISE</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Conor Medsystems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Conor Medsystems</source>
  <brief_summary>
    <textblock>
      To evaluate product performance and safety of the Catheter Design for the treatment of a
      single coronary lesion.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    CoStar Stent IDE failed to meet primary endpoint
  </why_stopped>
  <start_date>February 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">58</enrollment>
  <condition>Symptomatic Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>OTW Catheter System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Costar Coronary Stent Delivery System</intervention_name>
    <arm_group_label>OTW Catheter System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Patient is ≥18 years of age.

          2. Eligible for percutaneous coronary intervention (PCI).

          3. Documented stable or unstable angina pectoris (Canadian Cardiovascular Society
             Classification [CCS] 1, 2, 3, or 4), documented ischemia, or documented silent
             ischemia.

          4. Left ventricular ejection fraction (LVEF) ≥25% documented within the last 6 weeks.

          5. Acceptable candidate for coronary artery bypass graft surgery (CABG).

          6. Patient understands the study requirements and the treatment procedures and provides
             written Informed Consent using a form that has been approved by the local
             Institutional Review Board or Ethics Committee before any study-specific tests or
             procedures are performed.

          7. Willing to comply with all specified follow-up evaluations.

        Inclusion Criteria (Angiographic):

          1. A single de novo lesion per study subject may be treated with the study device.

          2. Each target lesion may be composed of multiple lesions but must be completely
             coverable by one (1) study stent.

          3. Cumulative target lesion length per vessel is ≤24 mm based on a visual estimate.

          4. RVD of ≥2.5 mm to ≤3.0 mm based on a visual estimate.

          5. Target lesion diameter stenosis ≥50% and &lt;100% based on a visual estimate.

          6. Target vessel has not undergone prior revascularization within the preceding 6 months.

          7. Target lesion must be a minimum of 10 mm distance from any previously treated segment
             of the target vessel

        Exclusion Criteria:

          1. Known sensitivity to cobalt chromium, paclitaxel or polymeric matrices: PLGA.

          2. Planned treatment with any other PCI device in the target vessel(s).

          3. Acute MI within 72 hours prior to the index procedure as defined by the presence of a
             new pathologic Q wave, or creatinine kinase (CK) &gt;2 times the laboratory upper limits
             of normal and elevated MB.

          4. The patient is in cardiogenic shock.

          5. Cerebrovascular Accident (CVA) within the past 6 months.

          6. Acute or chronic renal dysfunction (creatinine &gt;2.0 mg/dl or &gt;150 µmol/L).

          7. Contraindication to ASA or to clopidogrel.

          8. Thrombocytopenia (platelet count &lt;100, 000/mm3).

          9. Active gastrointestinal (GI) bleeding within the past three months.

         10. Any prior true anaphylactic reaction to contrast agents.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>Herz-Kreislauf-Zentrum</name>
      <address>
        <city>Am Kurpark 1</city>
        <state>Segeberger Kliniken GmbH</state>
        <zip>23795</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 9, 2009</study_first_submitted>
  <study_first_submitted_qc>October 9, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 12, 2009</study_first_posted>
  <last_update_submitted>October 27, 2009</last_update_submitted>
  <last_update_submitted_qc>October 27, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 29, 2009</last_update_posted>
  <responsible_party>
    <name_title>Sid Cohen, M.D.</name_title>
    <organization>Cordis</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

